Tarragon Allergy: The Artemisia Herb That Produces Zero Pollen in Culinary Form

No, French tarragon (Artemisia dracunculus var. sativa) does not produce pollen because it is propagated entirely through vegetative cuttings and root division rather than seeds. The culinary variety grown in gardens and sold commercially is a sterile clone that does not flower under normal cultivation conditions. This means it cannot cause pollen allergies in the traditional sense. Russian tarragon (A. dracunculus var. inodora) does flower and produce some pollen, but it is a different cultivar with weaker flavor that is rarely used in culinary applications. When patients report allergy symptoms while gardening near tarragon plants, the cause is almost always concurrent grass, weed, or tree pollen rather than the tarragon itself.

Estragole, also known as methyl chavicol, is a phenylpropanoid compound that constitutes 60 to 75 percent of French tarragon essential oil and gives the herb its characteristic anise-like flavor and aroma. As a contact allergen, estragole acts as a hapten — a small molecule that cannot trigger an immune response on its own but becomes immunogenic when it binds to skin proteins. Once the immune system recognizes the estragole-protein complex, subsequent skin contact produces allergic contact dermatitis with erythema, vesicles, and pruritus. Estragole is also found in basil, fennel, and anise, meaning patients sensitized through tarragon exposure may cross-react with these herbs. The compound has been classified as possibly carcinogenic by the International Agency for Research on Cancer, but this applies to high-dose essential oil use rather than normal culinary consumption.

Celery-mugwort-spice syndrome is a well-documented IgE cross-reactivity pattern where patients sensitized to mugwort pollen (Artemisia vulgaris) develop allergic reactions to multiple foods and spices that share homologous proteins. The primary sensitizing allergens are Art v 1 (a defensin-like protein) and Art v 4 (a profilin). These IgE antibodies cross-react with homologous proteins in celery, carrot, fennel, coriander, cumin, anise, and other Apiaceae and Asteraceae members. Tarragon fits this pattern because it belongs to the same genus as mugwort (both are Artemisia species) and shares closely related protein structures. A patient with confirmed mugwort pollen allergy who experiences oral symptoms after eating fresh tarragon is likely experiencing this cross-reactivity rather than a primary tarragon-specific allergy.

Many patients who react to raw fresh tarragon can tolerate cooked preparations because heat denatures the labile proteins responsible for cross-reactive oral allergy syndrome. The PR-10 and profilin proteins that drive celery-mugwort-spice syndrome reactions are thermolabile, meaning they lose their three-dimensional structure and IgE-binding capacity at cooking temperatures. Tarragon in bearnaise sauce, baked chicken, soups, and stews has typically been heated sufficiently to reduce or eliminate cross-reactive protein activity. However, this applies specifically to protein-mediated oral allergy reactions. If your reaction involves estragole contact sensitization (skin rash from handling the herb), cooking does not eliminate estragole entirely, and residual compounds in cooked dishes could theoretically trigger reactions in highly sensitized individuals, though this is uncommon with normal culinary concentrations.

Tarragon contains approximately 0.2 percent sesquiterpenoids, which is remarkably low compared to other Asteraceae (Compositae) family members like chamomile, arnica, chrysanthemum, and feverfew that are notorious for sesquiterpene lactone contact allergy. This chemical difference has practical clinical significance: patients who test positive on the Compositae mix patch test (which screens for sesquiterpene lactone sensitivity) are typically reacting to other Asteraceae members rather than tarragon specifically. The low sesquiterpene lactone content means tarragon-allergic patients are more likely sensitized through the estragole pathway than through the classic Compositae contact allergy mechanism. This distinction matters for avoidance counseling because a patient with Compositae mix-positive contact allergy may not need to avoid tarragon, while a patient with estragole sensitivity should avoid tarragon even though standard Compositae patch testing may be negative.

Tarragon essential oil is not recommended for individuals with known tarragon sensitivity because it contains concentrated estragole at levels far exceeding those in the fresh herb. A single drop of tarragon essential oil may contain as much estragole as several tablespoons of fresh tarragon leaves, dramatically increasing the risk of contact sensitization or triggering a reaction in already-sensitized individuals. Aromatherapy diffusers can disperse volatile estragole into the air, potentially causing respiratory irritation even in people without established sensitization. Topical application of undiluted or poorly diluted tarragon essential oil poses the highest risk for contact dermatitis. Patients with tarragon allergy should also be cautious with essential oil blends marketed for digestive support or muscle relaxation, as these frequently contain tarragon oil without prominent labeling.

Tarragon and mugwort are both Artemisia species but differ fundamentally in their clinical allergy profiles. Mugwort (Artemisia vulgaris) is wind-pollinated and one of the most important weed pollen allergens worldwide, with well-characterized allergens (Art v 1 through Art v 6) causing classical hay fever — sneezing, rhinorrhea, conjunctivitis — during its late summer pollen season. It is the primary sensitizer in the celery-mugwort-spice syndrome. French tarragon does not flower or produce pollen, so it cannot cause hay fever. Tarragon allergy manifests as contact dermatitis from estragole exposure or as oral allergy syndrome driven by pre-existing mugwort sensitization. In clinical terms, mugwort is the upstream cause and tarragon is a downstream cross-reactor. Treating the mugwort sensitization through immunotherapy can reduce tarragon-related oral symptoms, but treating tarragon contact allergy requires avoidance strategies rather than immunotherapy.

Immunotherapy can help with tarragon allergy symptoms, but only when those symptoms stem from underlying mugwort pollen sensitization through the celery-mugwort-spice syndrome pathway. Sublingual immunotherapy targeting mugwort pollen allergens gradually desensitizes the immune system to Art v 1 and other Artemisia proteins, which can reduce the cross-reactive IgE response that causes oral allergy symptoms when eating tarragon, celery, carrot, fennel, and related foods. Many patients notice reduced food and spice cross-reactivity within the first year of treatment. However, immunotherapy does not address estragole-mediated contact dermatitis because that follows a T-cell-mediated Type IV pathway rather than the IgE-mediated Type I pathway that immunotherapy modifies. Patients with isolated contact dermatitis from tarragon handling should focus on avoidance measures and dermatological management rather than immunotherapy.

If your tarragon allergy stems from mugwort cross-reactivity through the celery-mugwort-spice syndrome, you should be aware of the full spectrum of potentially cross-reactive foods and spices. The highest-risk items include raw celery and celeriac, raw carrot, fennel, coriander (cilantro), cumin, anise, and caraway — all Apiaceae family members with documented cross-reactivity to mugwort Art v 1 and Art v 4. Other Artemisia-related herbs including chamomile tea and absinthe (made from wormwood, another Artemisia species) may also trigger reactions. Importantly, cooking often reduces or eliminates symptoms because the relevant cross-reactive proteins are heat-labile. Many patients with this syndrome can eat cooked carrots, celery in soups, and herbs in baked dishes without difficulty. Keep a food-symptom diary to identify your specific trigger profile, as not all mugwort-sensitized patients react to the same cross-reactive foods.

The International Agency for Research on Cancer has classified estragole as a Group 2B substance — possibly carcinogenic to humans — based on animal studies showing liver tumors at very high doses. However, this classification applies to concentrated essential oil exposure rather than normal culinary use of tarragon. The European Food Safety Authority has noted that dietary exposure to estragole through herbs and spices is generally several orders of magnitude below the doses that produced effects in animal studies. Culinary use of tarragon in cooking — adding leaves to sauces, soups, and salads — exposes you to estragole levels well within the range that regulatory bodies consider acceptable for normal consumption. The concern is more relevant for individuals who consume tarragon essential oil supplements or use highly concentrated tarragon extracts regularly. From an allergy perspective, the carcinogenicity question is separate from the contact sensitization risk — you can be allergic to estragole at concentrations far below any carcinogenic concern.